[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cybb-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CYBB Gene",4,[7,15,22,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05189925","NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)",[11],"Phase 1","RECRUITING","2026-08-26T02:18:04.640417Z","2026-05-05T02:43:27.856369Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06325709","Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease",[19],"Phase 1\u002FPhase 2","2026-08-26T02:19:30.857183Z","2026-05-05T02:43:27.591969Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06876363","Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease",[19],"2026-08-03T02:56:00.496454Z","2026-05-05T02:35:31.714373Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06605378","Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease",[],"2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.554315Z"]